July 2012
Bayer Healthcare settles aspirin marketing lawsuit for $15 million
- Thu, 07/12/2012 - 12:32pm
A Bayer AG unit will pay $15 million to resolve a U.S. lawsuit regarding illegally marketed aspirin that contained supplements.
Newly approved Myrbetriq eases overactive bladder condition
- Wed, 07/11/2012 - 2:07pm
Overactive bladder and Myrbetriq
The U.S. Food and Drug Administration recently approved Myrbetriq to treat adults suffering from overactive bladder.
Lilly granted Cymbalta marketing extension
- Wed, 07/11/2012 - 11:32am
The U.S. Food and Drug Administration granted Eli Lilly & Co. six more months to market the Cymbalta.
Medicaid patients sue D.C. over drug denials
- Mon, 07/09/2012 - 4:22pm
Patients denied prescription drug coverage
Another Canadian study confirms Actos-bladder cancer link
- Mon, 07/09/2012 - 4:09pm
A recent Canadian study reveals a connection between popular type 2 diabetes drug Actos and bladder cancer.
FDA approves at-home HIV test
- Thu, 07/05/2012 - 2:21pm
In the event you’ve put yourself at risk for HIV infection – or just want to take responsible precautions – but are too embarrassed to visit a clinic and get tested, the U.S.
Accutane claims lead to compensation
- Thu, 07/05/2012 - 10:30am
Jurors only deliberated six hours before forcing Roche Holding to pay a total of $18 million to two Accutane users who suffered inflammatory bowel disease as a result of taking the acne medication.
GlaxoSmithKline lowers dosage to protect your heart
- Thu, 07/05/2012 - 9:33am
GlaxoSmithKline LLC has lowered Zofran’s dosage label after preliminary results of a clinical study revealed a risk of developing an abnormal heart rhythm.
FDA, companies to study metal-on-metal implant effects
- Mon, 07/02/2012 - 4:06pm
The FDA recently asked a panel of experts to recommend guidelines for monitoring over 500,000 patients with metal-on-metal hip replacements.